Intravenous self-administration of gamma-hydroxybutyrate (GHB) in baboons

Drug and Alcohol Dependence

Volumn 114, Issue 2-3, 2011, Pages 217-224

  Goodwin, Amy K ^a   Kaminski, Barbara J ^a   Griffiths, Roland R ^a   Ator, Nancy A ^a   Weerts, Elise M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abuse liability; Cocaine; Gamma hydroxybuturate (GHB); Operant behavior; Self administration; Xyrem

Indexed keywords

4 HYDROXYBUTYRIC ACID; COCAINE; DRUG VEHICLE;

ANIMAL EXPERIMENT; ARTICLE; BABOON; CONTROLLED STUDY; DRUG ABUSE; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ADDICTIVE; CONDITIONING, OPERANT; INJECTIONS, INTRAVENOUS; MALE; PAPIO; PAPIO HAMADRYAS; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SODIUM OXYBATE;

ANIMALIA; PAPIO; PRIMATES;

EID: 79952696786     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.10.006     Document Type: Article

References (61)

1. Abanades S., Farre M., Segura M., Pichini S., Barral D., Pacifici R., Pellegrini M., Fonseca f., Langohr K., De la Torre R. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann. N Y Acad. Sci. 2006, 1074:559-576.
2. Addolorato G., Capristo E., Gessa G.L., Caputo F., Stefanini G.F., Gasbarrini G. Long-term administration of GHB does not affect muscular mass in alcoholics. Life Sci. 1999, 65:L191-196.
3. Addolorato G., Castelli E., Stefanini G.F., Casella G., Caputo F., Marsigli L., Bernardi M., Gasbarrini G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol. 1996, 31:341-345. GHB.
4. Addolorato G., Leggio L., Ferrulli A., Caputo F., Gasbarrini A. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert Opin. Investig. Drugs 2009, 18:675-686.
5. Ator N.A. Zaleplon and triazolam: drug discrimination, plasma levels and self-administration in baboons. Drug Alcohol Depend. 2000, 61:55-68.
6. Ator N.A., Atack J.R., Hargreaves R.J., Burns H.D., Dawson G.R. Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes. J. Pharmacol. Exp. Ther. 2010, 332:4-16.
7. Ator N.A., Griffiths R.R. Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend. 2003, 70:S55-S72.
8. Ator N.A., Weerts E.M., Kaminski B.J., Kautz M.A., Griffiths R.R. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug Alcohol Depend. 2000, 61:69-84.
9. Ator N.A., Griffiths R.R., Weerts E.M. Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons. Drug Alcohol Depend. 2005, 78(2):113-123.
10. Beardsley P.M., Balster R.L., Harris L.S. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology (Berl.) 1996, 127:315-322.
11. Broughton R., Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can. J. Neurol. Sci. 1979, 6:1-6.
12. Carter L.P., Griffiths R.R. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend. 2009, 105(Suppl. 1):S14-25.
13. Carter L.P., Griffiths R.R., Mintzer M.Z. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacology (Berl.) 2009, 206:141-154.
14. Carter L.P., Pardi D., Gorsline J., Griffiths R.R. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug Alcohol Depend. 2009, 104:1-10.
15. Carter L.P., Richards B.D., Mintzer M.Z., Griffiths R.R. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of traizolam, pentobarbital, and GHB. Neuropsychopharmacology 2006, 1-15. (epub ahead of print).
16. Carter L.P., Wu H., Chen W., Cruz C.M., Lamb R.J., Koek W., Coop A., France C.P. Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABA-B receptors. J. Pharmacol. Exp. Ther. 2004, 308:182-188.
17. Colombo G., Agabio R., Balaklievskaia N., Diaz G., Lobina C., Reali R., Gessa G. Oral self-administration of gamma-hydroxybutyric acid in the rat. Eur. J. Pharmacol. 1995, 285:103-107.
18. Colombo G., Agabio R., Diaz G., Fa M., Lobina C., Reali R., Gessa G. Gamma-hydroxybutyric acid intake in ethanol-preferring sP and -nonpreferring sNP rats. Physiol. Behav. 1998, 64:197-202.
19. Craig K., Gomez H., McManus J., Bania T. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J. Emerg. Med. 2000, 18:65-70.
20. DEA/ODE Gamma Hydroxybutyric Acid (GHB, liquid X, Goop, Georgia Home Boy) 2000, Drug Enforcement Ageny, Office of Diversion Control, Washington, DC.
21. Degenhardt L., Darke S., Dillon P. GHB use among Australians: characteristics, use patterns and associated harm. Drug Alcohol Depend. 2002, 67:89-94.
22. Dyer J., Roth B., Hyma B. Gamma-hydroxybutyrate withdrawal syndrome. Ann. Emerg. Med. 2001, 37:147-153.
23. Fantegrossi W.E., Woods J.H., Winger G. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behav. Pharmacol. 2004, 15:149-157.
24. Fattore L., Martellotta M., Cossu G., Fratta W. Gamma-hydroxybutyric acid: an evaluation of its rewards properties in rats and mice. Alcohol 2000, 20:247-256.
25. Galloway G., Frederick-Osborne S., Seymour R., Contini S., Smith D. Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol 2000, 20:263-269.
26. Galloway G., Frederick S., Staggers F., Gonzales M., Stalcup S., Smith D. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997, 92:89-96.
27. Galloway G.P., Frederick-Osborne S.L., Seymour R., Contini S.E., Smith D.E. Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol 2000, 20:263-269.
28. Gonzalez A., Nutt D.J. Gamma hydroxy butyrate abuse and dependency. J. Psychopharamacol. 2005, 19:195-204.
29. Goodwin A.K., Froestl W., Weerts E.M. Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in Baboons. Psychopharmacolgy 2005, 180:342-351.
30. Griffiths R.R., Brady J.V., Bradford L.D. Predicting the abuse liability of drugs with animal drug self-administration prodcedures: psychomotor stimulants and hallucinogens. Advances in Behavioral Pharmacology 1979, 163-208. Academic Press, New York. T. Thompson, P.B. Dews (Eds.).
31. Griffiths R.R., Johnson M.W. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J. Clin. Psychiatr. 2005, 66(Suppl. 9):31-41.
32. Griffiths R.R., Lamb R.J., Sannerud C.A., Ator N.A., Brady J.V. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology 1991, 103:154-161.
33. Griffiths R.R., Sannerud C.A., Ator N.A., Brady J.V. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J. Pharmacol. Exp. Ther. 1992, 260:1199-1208.
34. Griffiths R.R., Weerts E.M. Benzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abuse. Psychopharmacology (Berl.) 1997, 134:1-37.
35. Griffiths R.R., Wolf B. Relative abuse liability of different benzodiazepines in drug abusers. J. Clin. Psychopharmacol. 1990, 10:237-243.
36. Hutto B., Fairchild A., Bright R. gamma-Hydroxybutyrate withdrawal and chloral hydrate. Am. J. Psychiatr. 2000, 157:1706.
37. Itzhak Y., Ali S. Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann. N Y Acad. Sci. 2002, 965:451-460.
38. Johanson C.E., Balster R.L. A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull. Narc. 1978, 30:43-54.
39. Kaminski B.J., Griffiths R.R. Intravenous self-injection of methcathinone in the baboon. Pharmacol. Biochem. Behav. 1994, 47:981-983.
40. Kaminski B.J., Sannerud C.A., Griffiths R.R. Intravenous self-injection of psychomotor stimulant-anorectics in the baboons. Exp. Clin. Psychopharmacol. 1996, 4:141-150.
41. Koek W., Flores L.R., Carter L.P., Lamb R.J., Chen W., Wu H., Coop A., France C.P. Discriminative stimulus effects of {gamma}-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABAA and GABAB receptors. J. Pharmacol. Exp. Ther. 2004, 308:904-911.
42. Laborit H. Gamma-hydroxybutyrate, succinic semialdehyde and sleep. Prog. Neurobiol. 1973, 1:257-274.
43. Lukas S., Griffiths R., Bradford L., JV B., Daley L. A tethering system for intravenous and intragastric drug administration in the baboon. Pharmacol. Biochem. Behav. 1982, 17:823-829.
44. Mamelak M., Scharf M., Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate: a review of clinical and sleep laboratory findings. Sleep 1986, 9:285-289.
45. Martellotta M., Cossu G., Fattore L., Gessa G., Fratta W. Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice. Eur. Neuropsychopharmacol. 1998, 8:293-296.
46. Martellotta M.C., Fattore L., Cossu G., Fratta W. Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology (Berl.) 1997, 132:1-5.
47. Miotto K., Darakjian J., Basch J., Murray S., Zogg J., Rawson R. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am. J. Addict. 2001, 10:232-241.
48. Nicholson K.L., Balster R.L. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 2001, 63:1-22.
49. Panlilio L.V., Goldberg S.R. Self-administration of drugs in animals and humans as a model and an investigative tool. Addiction 2007, 102(12):1863-1870.
50. Scharf M., Brown D., Woods M., Brown L., Hirschowitz J. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J. Clin. Psychiatr. 1985, 46:222-225.
51. Scrima L., Hartman P., Johnson F., Thomas E., Hiller F. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep 1990, 13:479-490.
52. U.S.Xyrem® Multicenter Study Group Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 2004, 119-123.
53. Watson J., Guzzetti S., Franchi C., Di Clemente A., Burbassi S., Emri Z., Leresche N., Parri H.R., Crunelli V., Cervo L. Gamma-hydroxybutyrate does not maintain self-administration but induces conditioned place preference when injected in the ventral tegmental area. Int. J. Neuropsychopharmacol. 2009, 1-11.
54. Wedin G., Hornfeldt C., Ylitalo L. The clinical development of gamma-hydroxybyrate (GHB). Curr. Drug Safety 2006, 1:99-106.
55. Weerts E.M., Ator N.A., Griffiths R.R. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug Alcohol Depend. 1999, 57:51-60.
56. Weerts E.M., Fantegrossi W.E., Goodwin A.K. The value of nonhuman primates in drug abuse research. Exp. Clin. Psychopharmacol. 2007, 15:309-327.
57. Weerts E.M., Froestl W., Kaminski B.J., Griffiths R.R. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend. 2007, 89:206-213.
58. Weerts E.M., Goodwin A.K., Griffiths R.R., Brown P.R., Froestl W., Jakobs C., Gibson K.M. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology 2005, 179:678-687.
59. Weerts E.M., Griffiths R.R. Evaluation of the intravenous reinforcing effects of clonidine in baboons. Drug Alcohol Depend. 1999, 53:207-214.
60. Wong C.G., Gibson K.M., Snead O.C., 3rd From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol. Sci. 2004, 25:29-34.
61. Woolverton W.L., Rowlett J.K., Winger G., Woods J.H., Gerak L.R., France C.P. Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug Alcohol Depend. 1999, 54:137-143.